Explore articles, research, and perspectives from the International Perfusion Association.
This study evaluates the impact of a revised myocardial protection protocol implemented in 2021 at St. Marianna University School of Medicine for patients undergoing
Four studies explore blood conservation strategies following cardiopulmonary bypass (CPB) in adult cardiac surgery. Techniques like centrifugation (CF), modified ultrafiltration (MUF), and Hemobag (HB)
This study analyzed 130 adult cardiac surgery patients to identify perioperative predictors of prolonged ICU stays and in-hospital mortality. Results revealed aortic cross-clamp time
This retrospective cohort study assessed the effect of prolonged cardiopulmonary bypass (CPB ≥ 120 minutes) on gastrointestinal complications (GICs) after cardiac surgery. Analyzing 1,444
This study developed and validated the SDACS screening tool to predict postoperative delirium in cardiac surgery patients. Conducted across three academic hospitals with 920
This article explores vasoplegic syndrome (VS), a serious complication following cardiac surgery involving cardiopulmonary bypass. It discusses inconsistent definitions, risk factors, and treatment strategies.
This study investigates the effects of systemic inflammatory response syndrome (SIRS) on 30-day mortality following cardiac surgery and develops machine learning models to predict
This study assessed whether intraoperative renal near-infrared spectroscopy (NIRS) could predict acute renal failure (ARF) in 357 cardiac surgery patients. It found that longer
This study compares Del Nido (DN) and Bretschneider histidine-tryptophan-ketoglutarate (HTK) cardioplegia solutions in a porcine model of prolonged ischaemia. DN demonstrated superior left ventricular
A post-hoc analysis of the ALBICS randomized trial with 1,386 cardiac surgery patients found that perioperative bleeding, as classified by the Universal Definition of
This study compared six Health Canada-approved cardiopulmonary bypass (CPB) circuits in 872 cardiac surgery patients to assess their effects on bleeding and coagulation. While
This case study reports on the successful intraoperative removal of apixaban using a CytoSorb hemoadsorption device during emergency heart transplantation. The 61-year-old patient, previously
